Evidence map›Paper›PMID 37140947›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2023

Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD.

Eva Pappe, Ralf Hammerich, Jacopo Saccomanno, Thomas Sgarbossa, Anne Pohrt, Bernd Schmidt, Christian Grah, Stephan Eisenmann, Angelique Holland, Stephan Eggeling and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Trend control charts for multiple sclerosis case definitions.International journal of population data science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Eva PappeDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ralf HammerichAdministrative Office for Clinical Quality and Risk Management, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Jacopo SaccomannoDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thomas SgarbossaDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Anne PohrtInstitute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Bernd SchmidtDepartment of Respiratory Medicine, DRK Kliniken Berlin Mitte, Berlin, Germany.
Christian GrahDepartment of Internal Medicine and Respiratory Medicine, Clinic Havelhöhe Berlin, Berlin, Germany.
Stephan EisenmannDepartment of Internal Medicine I, Pulmonary Medicine, University Hospital Halle (Saale), Germany.
Angelique HollandDepartment of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, Germany.
Stephan EggelingDepartment of Thoracic Surgery, Vivantes Netzwerk für Gesundheit, Klinikum Neukölln, Berlin, Germany.
Franz StanzelLungenklinik Hemer, Hemer, Germany.
Martin WitzenrathDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ralf-Harto HübnerDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEDRK Kliniken Berlin · DEForschungsinstitut Havelhöhe · DELungenklinik Hemer · DEUniversity Hospital in Halle · DEVivantes Klinikum · DE

Funding

CapNetz StiftungGerman Federal Ministry of Education and Research (BMBF) CAP-TSD/031L0286BGerman Federal Ministry of Education and Research (BMBF) E:Med CAPSYS/01ZX1604BGerman Federal Ministry of Education and Research (BMBF) e:Med SYMPATH/01ZX1906AGerman Federal Ministry of Education and Research (BMBF) MAPVAP/01KI2124German Federal Ministry of Education and Research (BMBF) NUM-NAPKON/01KX2021German Federal Ministry of Education and Research (BMBF) NUM-NAPKON /01KX2121German Federal Ministry of Education and Research (BMBF) Phage4Cure/16GW0141German Federal Ministry of Education and Research (BMBF) PROVID/01KI20160AGerman Federal Ministry of Education and Research (BMBF) PulmVasC/01EP2102BGerman Research Foundation B02German Research Foundation C09German Research Foundation CO6German Research Foundation SFB1449/114933180German Research Foundation SFB-TR84/114933180Lungenemphysem Register e.V.
6 · The paper itself

Abstract

Introduction: Patients with chronic obstructive pulmonary disease (COPD) have an increased risk of acquiring severe coronavirus disease 2019 (COVID-19), which is why self-isolation was recommended. However, long periods of social isolation, accompanied by limited access to health care systems, might influence the outcome of patients with severe COPD negatively. Methods: Data from COPD and pneumonia patients at Charité-Universitätsmedizin Berlin and the volume of endoscopic lung volume reduction (ELVR) surgeries from the German Lung Emphysema Registry ( Results: Admissions and ventilation therapies administered to COPD patients significantly decreased during the COVID-19 pandemic. Likewise, there was a reduction in ELVR treatments and follow-ups registered in German emphysema centers. Mortality was slightly higher among patients hospitalized with COPD during the pandemic. Increasing proportions of COPD patients with GOLD stage 3 and GOLD stage 4 status reported behavioral changes and subjective feelings of increasing COPD symptoms the longer the lockdown lasted. However, COPD symptom questionnaires revealed stable COPD symptoms over the pandemic time period. Summary: This study reveals reduced COPD admissions and elective treatment procedures of COPD patients during the pandemic, but a slight increase in mortality among patients hospitalized with COPD, irrespective of COVID-19. Correspondingly, patients with severe COPD reported subjective deterioration of their health status, probably caused by their very strict compliance with lockdown measures.

Indexed as

COPDCOVID-19endoscopic lung volume reductionlockdown measures

Identifiers

PMID37140947
PMCPMC10484494
OpenAlexW4368283200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.